180 related articles for article (PubMed ID: 36111679)
1. 'Mistakes in managing non-alcoholic fatty liver disease and how to avoid them'.
Niriella MA; Dassanayake U; de Silva HJ
Scand J Gastroenterol; 2023 Mar; 58(3):223-226. PubMed ID: 36111679
[TBL] [Abstract][Full Text] [Related]
2. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
[TBL] [Abstract][Full Text] [Related]
3. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
Blond E; Disse E; Cuerq C; Drai J; Valette PJ; Laville M; Thivolet C; Simon C; Caussy C
Diabetologia; 2017 Jul; 60(7):1218-1222. PubMed ID: 28352941
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.
Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK
Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease: a diabetologist's perspective.
Pappachan JM; Antonio FA; Edavalath M; Mukherjee A
Endocrine; 2014 Apr; 45(3):344-53. PubMed ID: 24287794
[TBL] [Abstract][Full Text] [Related]
6. Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).
Brain D; O'Beirne J; Hickman IJ; Powell EE; Valery PC; Kularatna S; Tulleners R; Farrington A; Horsfall L; Barnett A
BMC Health Serv Res; 2020 Apr; 20(1):335. PubMed ID: 32316984
[TBL] [Abstract][Full Text] [Related]
7. Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver disease.
van Dijk AM; Schattenberg JM; Holleboom AG; Tushuizen ME
United European Gastroenterol J; 2021 Oct; 9(8):903-909. PubMed ID: 34609086
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Yamamura S; Nakano D; Hashida R; Tsutsumi T; Kawaguchi T; Okada M; Isoda H; Takahashi H; Matsuse H; Eguchi Y; Sumida Y; Nakajima A; Gerber L; Younossi ZM; Torimura T
J Gastroenterol Hepatol; 2021 Mar; 36(3):629-636. PubMed ID: 32627871
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease.
Boursier J; Guillaume M; Bouzbib C; Lannes A; Pais R; Smatti S; Cariou B; Bureau C; Ganne-Carrié N; Bourlière M; de Lédinghen V
Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101769. PubMed ID: 34332133
[TBL] [Abstract][Full Text] [Related]
10. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
[TBL] [Abstract][Full Text] [Related]
11. Managing non-alcoholic fatty liver disease.
Ngu JH; Goh GB; Poh Z; Soetikno R
Singapore Med J; 2016 Jul; 57(7):368-71. PubMed ID: 27439352
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes.
Kuchay MS; Choudhary NS; Mishra SK; Misra A
Diabetes Metab Syndr; 2020; 14(6):2233-2239. PubMed ID: 33336648
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease - A global public health perspective.
Younossi ZM
J Hepatol; 2019 Mar; 70(3):531-544. PubMed ID: 30414863
[TBL] [Abstract][Full Text] [Related]
14. Management of NAFLD in primary care settings.
Wong VWS; Zelber-Sagi S; Cusi K; Carrieri P; Wright E; Crespo J; Lazarus JV
Liver Int; 2022 Nov; 42(11):2377-2389. PubMed ID: 35986897
[TBL] [Abstract][Full Text] [Related]
15. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Johnston MP; Patel J; Byrne CD
Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
[TBL] [Abstract][Full Text] [Related]
16. Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease.
Rowe IA
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):66-72. PubMed ID: 29254617
[TBL] [Abstract][Full Text] [Related]
17. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes.
Gracen L; Hayward KL; Aikebuse M; Russell A; O'Beirne J; McPhail S; Irvine KM; Williams S; Valery PC; Powell EE
BMC Health Serv Res; 2022 Apr; 22(1):487. PubMed ID: 35413987
[TBL] [Abstract][Full Text] [Related]
18. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
Aller R; Fernández-Rodríguez C; Lo Iacono O; Bañares R; Abad J; Carrión JA; García-Monzón C; Caballería J; Berenguer M; Rodríguez-Perálvarez M; Miranda JL; Vilar-Gómez E; Crespo J; García-Cortés M; Reig M; Navarro JM; Gallego R; Genescà J; Arias-Loste MT; Pareja MJ; Albillos A; Muntané J; Jorquera F; Solà E; Hernández-Guerra M; Rojo MÁ; Salmerón J; Caballería L; Diago M; Molina E; Bataller R; Romero-Gómez M
Gastroenterol Hepatol; 2018 May; 41(5):328-349. PubMed ID: 29631866
[TBL] [Abstract][Full Text] [Related]
19. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
[TBL] [Abstract][Full Text] [Related]
20. The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016.
Townsend SA; Newsome PN
Dig Dis; 2017; 35(4):371-376. PubMed ID: 28468015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
